Not applicableActive Not RecruitingNCT07498400
What this trial is testing
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer
Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))Breast Cancer
Xijing Hospital 216